Jerald Smolkin, MD Candidate 2028
About Me
I’m a first-year medical student at Ponce Health Sciences University (PHSU) with an M.S. in Biology and time in a toxicology lab, and I kept noticing the same pattern: patients making supplement decisions based on Reddit threads, Amazon ratings, and influencer hype while the real clinical signals from licensed professionals is nowhere to be found. This gap pushed me to launch SupDoc—the first verified review network where physicians, pharmacists, dietitians, and other credentialed clinicians can rate and discuss over-the-counter supplements. Every reviewer is NPI-verified; every product page shows 1–5-star ratings, evidence tags, and open-text commentary; and every review is ethically sponsored (clearly labeled, clinician-paid). On the back end we aggregate those reviews into de-identified trend reports—revealing real-world efficacy signals, emerging side-effect patterns, and off-label clinical pearls that have never been visible at scale.
You have not backed any projects.
Lets change that!
Discover Projects
No project created yet.
Lets change that!
Discover Projects
No comments on any project yet.
Lets change that!
Discover Projects
No likes on any project yet..
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No data found.
Lets change that!
Discover Projects
No project reviewed yet.
Lets change that!
Discover Projects
Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.